ARTICANZ - Beta (ver 0.9)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - target/TP53-Y220C
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
target/TP53-Y220C
1
trial(s) found.
NCT04585750
Advanced
Phase 1 / Phase 2
Recruiting
A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients With Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (
PMV-586-101
)
mutant p53 reactivator,Y220C-selective
+ cancer therapy,TP53 Y220C-targeting
Bladder cancer
Breast cancer
Colorectal cancer
Endometrial cancer
HER2-negative breast cancer
HER2-positive breast cancer
Head and neck cancer
Lung cancer
Non-small cell lung cancer
Ovarian cancer
Prostate cancer
Small-cell lung cancer
Triple-negative breast cancer
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
VIC
3168 - Clayton - Monash Medical Centre
QLD
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre
SA
5042 - Bedford Park - Flinders Medical Centre
WA
6009 - Nedlands - One Clinical Research
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (1)
Recruitment Country and State
NSW (1)
QLD (1)
SA (1)
VIC (1)
WA (1)
Phase
Phase 1 / Phase 2 (1)
Trial Type
Advanced (1)
Cancer Therapy Class
PD-1
100%
PD-1/PD-L1
100%
TP53
100%
TP53 Y220C
100%
Facility
2050 - Camperdown - Chris O'Brien Lifehouse (1)
3168 - Clayton - Monash Medical Centre (1)
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre (1)
5042 - Bedford Park - Flinders Medical Centre (1)
6009 - Nedlands - One Clinical Research (1)
Cancer Type
Bladder cancer
Breast adenocarcinoma
Breast cancer
Cancer
Carcinoma
Colorectal cancer
Endometrial cancer
Gastrointestinal cancer
Gynaecological cancer
HER2-negative breast cancer
HER2-positive breast cancer
Head and neck cancer
Lower gastrointestinal cancer
Lung cancer
Male genital cancers
Neuroendocrine carcinoma
Non-small cell lung cancer
Ovarian cancer
Prostate cancer
Respiratory tract cancer
Small-cell lung cancer
Small-cell neuroendocrine carcinoma
Solid tumour
Thoracic cancer
Triple-negative breast cancer
Urogenital cancer
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy